A new study—in mice—from Washington University School of Medicine in St. Louis suggests that blocking a major inflammatory pathway that is activated in pancreatic cancer makes the tumors sensitive to chemotherapy and ...
Mar 7, 2022
0
49
The survival rate of extremely preterm infants born from 2013 through 2018 in a large network of U.S. research centers improved to 78.3 percent, compared to 76 percent for infants born in the network from 2008 to 2012, according ...
Jan 19, 2022
0
4
(HealthDay)—Pregnant people with sickle cell trait (SCT) have increased risk of stillbirth, according to a study published online Nov. 24 in JAMA Network Open.
Dec 3, 2021
0
2
The U.S. Food and Drug Administration (FDA) today approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons ...
Nov 30, 2021
0
3
In a recent phase 2b/3 clinical trial, a third mRNA vaccine against COVID-19—known as CVnCoV and developed by CureVac—reported approximately 48 percent efficacy against symptomatic disease. CV2CoV is a second generation ...
Nov 18, 2021
0
170
The time required to secure prior authorization approvals for radiation therapy treatments equates to a financial impact of more than $40 million annually for academic medical centers, according to a new study. Findings will ...
Oct 25, 2021
0
0
In many ways, the COVID-19 pandemic forced positive changes in how medicine is practiced in communities and at academic medical centers, with Family Medicine departments working at the front lines to provide care and forge ...
Sep 17, 2021
0
2
In a retrospective study believed to be one of the largest of its kind, researchers say they have successfully charted the health risks, growth patterns, and medical and surgical outcomes of 1,374 people with the most common ...
Jun 21, 2021
0
3
Abusive head trauma (AHT) is one of the leading causes of traumatic death and disability in infants and young children in the United States. A missed diagnosis can lead to death if the child is mistakenly returned to an abusive ...
May 31, 2021
0
2
(HealthDay)—Chronic immune-related adverse effects after adjuvant treatment with anti-programmed cell death 1 (anti-PD-1) immunotherapies for melanoma are more common than previously thought, according to a study published ...
Apr 16, 2021
0
3
